Aarey Drugs & Pharmaceuticals has informed that the Board of Directors of the Company at its Meeting held on 14th February, 2025 have passed the following resolution: The Board of Directors of the Company has considered and approved the Unaudited Financial Results for the quarter ended 31st December, 2024 along with the Limited Review Report, MD/CFO certification. Company segment is single. The meeting was started at 06:00 pm and was concluded at 07:00 pm.
The above information is a part of company’s filings submitted to BSE.
